• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质膜钙ATP酶活性受损和线粒体功能障碍导致法布里病相关疼痛性神经病变中的钙调节异常。

Impaired plasma membrane calcium ATPase activity and mitochondrial dysfunction contribute to calcium dysregulation in Fabry disease-related painful neuropathy.

作者信息

Formaggio Francesco, Pizzi Asia, Delprete Cecilia, Pasqualini Davide, Mataloni Isabella, Rimondini Roberto, Campolongo Ludovica, Donadio Vincenzo, Ghelli Anna Maria, Liguori Rocco, Caprini Marco

机构信息

Laboratory of Cellular and Molecular Physiology, Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy.

Laboratory of Cellular and Molecular Physiology, Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy.

出版信息

Neurobiol Dis. 2025 Sep;213:107000. doi: 10.1016/j.nbd.2025.107000. Epub 2025 Jun 13.

DOI:10.1016/j.nbd.2025.107000
PMID:40516708
Abstract

Neuropathic pain is a hallmark symptom in Fabry disease (FD), a hereditary X-linked lysosomal storage disorder caused by a reduced activity of α-galactosidase A (α-Gal A). The α-Gal A deficiency results in the progressive accumulation of globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3) in the body fluids and lysosomes of various cell types, including sensory ganglia. The FD neuropathy affects the small thinly myelinated Aδ fibers and unmyelinated C fibers leading to the loss of intra-epidermal neuronal terminations, along with altered thermal and mechanical perception. Lipid accumulation, such as Gb3 and lyso-Gb3, is implicated in various cellular dysfunctions, including the alteration of ionic currents. It has been shown that administration of Gb3 to human umbilical vein endothelial cells leads to the downregulation of the calcium (Ca)-activated K channel K3.1, whereas lyso-Gb3 evokes cytosolic Ca transients and an enhancement of voltage-activated Ca currents in murine dorsal root ganglia. Therefore, we examined the mechanism underlying Ca regulation in primary afferent neurons from the α-Gal A (-/0) mouse model. The obtained results suggest that other transport proteins participate in Ca homeostasis in FD and their dysfunction may be directly involved in nociception. In this context, plasma-membrane Ca ATPases exhibited reduced activity in FD, leading to an increased resting [Ca] in sensory neurons. The reduced activity was associated with a decrease of cytosolic pH which weakened the PMCA-dependent calcium extrusion. We finally evaluated the contribution of mitochondria to the Ca signalling and we observed impairment of the mitochondrial buffer capacity, as well as dysfunctional mitochondria and enhanced autophagy/mitophagy. These findings provide a basis for future insights into the alterations of calcium signalling underlying the onset of neuropathic symptoms in FD.

摘要

神经性疼痛是法布里病(FD)的一个标志性症状,法布里病是一种遗传性X连锁溶酶体贮积症,由α-半乳糖苷酶A(α-Gal A)活性降低引起。α-Gal A缺乏导致球三糖神经酰胺(Gb3)和球三糖鞘氨醇(lyso-Gb3)在包括感觉神经节在内的各种细胞类型的体液和溶酶体中进行性蓄积。FD神经病变会影响细小的有髓Aδ纤维和无髓C纤维,导致表皮内神经末梢丧失,同时热觉和机械觉也会改变。脂质蓄积,如Gb3和lyso-Gb3,与包括离子电流改变在内的各种细胞功能障碍有关。研究表明,将Gb3施用于人脐静脉内皮细胞会导致钙(Ca)激活的钾通道K3.1下调,而lyso-Gb3会引起小鼠背根神经节中的胞质Ca瞬变并增强电压激活的Ca电流。因此,我们研究了α-Gal A(-/-0)小鼠模型初级传入神经元中Ca调节的潜在机制。所得结果表明,其他转运蛋白参与了FD中的Ca稳态,其功能障碍可能直接与伤害感受有关。在这种情况下,质膜Ca ATP酶在FD中的活性降低,导致感觉神经元的静息[Ca]增加。活性降低与胞质pH值降低有关,这削弱了PMCA依赖的钙外排。我们最终评估了线粒体对Ca信号传导的贡献,观察到线粒体缓冲能力受损,以及线粒体功能障碍和自噬/线粒体自噬增强。这些发现为深入了解FD神经性症状发作背后的钙信号改变提供了基础。

相似文献

1
Impaired plasma membrane calcium ATPase activity and mitochondrial dysfunction contribute to calcium dysregulation in Fabry disease-related painful neuropathy.质膜钙ATP酶活性受损和线粒体功能障碍导致法布里病相关疼痛性神经病变中的钙调节异常。
Neurobiol Dis. 2025 Sep;213:107000. doi: 10.1016/j.nbd.2025.107000. Epub 2025 Jun 13.
2
The use and performance of lyso-Gb3 for the diagnosis and monitoring of Fabry disease: A systematic literature review.溶血神经酰胺三己糖苷用于法布里病诊断和监测的应用及性能:一项系统文献综述
Mol Genet Metab. 2025 Jun;145(2):109110. doi: 10.1016/j.ymgme.2025.109110. Epub 2025 Apr 21.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Pain in fibrous dysplasia: identifying nociceptive mechanisms in a preclinical model.骨纤维发育不良中的疼痛:在临床前模型中识别伤害性感受机制。
J Bone Miner Res. 2025 Jun 25;40(7):891-903. doi: 10.1093/jbmr/zjaf039.
5
Anxiety-like behavior and altered hippocampal activity in a transgenic mouse model of Fabry disease.法布里病转基因小鼠模型中的焦虑样行为及海马体活动改变
Neurobiol Dis. 2025 Feb;205:106797. doi: 10.1016/j.nbd.2025.106797. Epub 2025 Jan 7.
6
Short-Term Memory Impairment短期记忆障碍
7
Early Atrial Remodeling Drives Arrhythmia in Fabry Disease.早期心房重构促使法布里病发生心律失常。
Circ Arrhythm Electrophysiol. 2025 Jul;18(7):e013352. doi: 10.1161/CIRCEP.124.013352. Epub 2025 Jun 25.
8
Nociceptive transient receptor potential ankyrin 1 (TRPA1) in sensory neurons are targets of the antifungal drug econazole.感觉神经元中的伤害性瞬时受体电位锚蛋白 1(TRPA1)是抗真菌药物益康唑的作用靶点。
BMC Pharmacol Toxicol. 2024 Aug 21;25(1):53. doi: 10.1186/s40360-024-00779-x.
9
Fabry disease - a risk factor for renal cell cancer? - case series.法布里病——肾细胞癌的一个危险因素?——病例系列
Mol Genet Metab. 2025 Aug;145(4):109157. doi: 10.1016/j.ymgme.2025.109157. Epub 2025 Jun 1.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.